Safety and Tolerability of Nexvax2 in Subjects With Celiac Disease

NCT02528799 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Celiac Disease

Interventions

BIOLOGICAL: Nexvax2
BIOLOGICAL: Nexvax2 placebo

Sponsor

ImmusanT, Inc.